Cargando…

Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis

Hepcidin, a major regulator of iron metabolism and homeostasis, is regulated by inflammation. Recent studies have suggested that hepcidin and iron metabolism are involved in osteoporosis, and the aim of this study was to determine whether serum hepcidin levels are correlated with the degree of osteo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Hiroe, Takai, Chinatsu, Kazama, Junichiro James, Wakamatsu, Ayako, Hasegawa, Eriko, Kobayashi, Daisuke, Kondo, Naoki, Nakatsue, Takeshi, Abe, Asami, Ito, Satoshi, Ishikawa, Hajime, Kuroda, Takeshi, Suzuki, Yoshiki, Narita, Ichiei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303107/
https://www.ncbi.nlm.nih.gov/pubmed/32555299
http://dx.doi.org/10.1038/s41598-020-66945-3
_version_ 1783547978933338112
author Sato, Hiroe
Takai, Chinatsu
Kazama, Junichiro James
Wakamatsu, Ayako
Hasegawa, Eriko
Kobayashi, Daisuke
Kondo, Naoki
Nakatsue, Takeshi
Abe, Asami
Ito, Satoshi
Ishikawa, Hajime
Kuroda, Takeshi
Suzuki, Yoshiki
Narita, Ichiei
author_facet Sato, Hiroe
Takai, Chinatsu
Kazama, Junichiro James
Wakamatsu, Ayako
Hasegawa, Eriko
Kobayashi, Daisuke
Kondo, Naoki
Nakatsue, Takeshi
Abe, Asami
Ito, Satoshi
Ishikawa, Hajime
Kuroda, Takeshi
Suzuki, Yoshiki
Narita, Ichiei
author_sort Sato, Hiroe
collection PubMed
description Hepcidin, a major regulator of iron metabolism and homeostasis, is regulated by inflammation. Recent studies have suggested that hepcidin and iron metabolism are involved in osteoporosis, and the aim of this study was to determine whether serum hepcidin levels are correlated with the degree of osteoporosis in patients with rheumatoid arthritis (RA). A total of 262 patients with RA (67.5 ± 11.4 years; 77.5% female) were enrolled. Serum iron, ferritin, and hepcidin levels were positively correlated each other. Multiple regression analyses revealed that the serum iron level was positively correlated with femoral T and Z scores, whereas the serum hepcidin level was not. Serum hepcidin level was correlated with the serum 25-hydroxy vitamin D level, which was in turn positively related to the femoral Z score. Serum hepcidin and serum iron were indirectly and directly related to osteoporosis in patients with RA.
format Online
Article
Text
id pubmed-7303107
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-73031072020-06-22 Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis Sato, Hiroe Takai, Chinatsu Kazama, Junichiro James Wakamatsu, Ayako Hasegawa, Eriko Kobayashi, Daisuke Kondo, Naoki Nakatsue, Takeshi Abe, Asami Ito, Satoshi Ishikawa, Hajime Kuroda, Takeshi Suzuki, Yoshiki Narita, Ichiei Sci Rep Article Hepcidin, a major regulator of iron metabolism and homeostasis, is regulated by inflammation. Recent studies have suggested that hepcidin and iron metabolism are involved in osteoporosis, and the aim of this study was to determine whether serum hepcidin levels are correlated with the degree of osteoporosis in patients with rheumatoid arthritis (RA). A total of 262 patients with RA (67.5 ± 11.4 years; 77.5% female) were enrolled. Serum iron, ferritin, and hepcidin levels were positively correlated each other. Multiple regression analyses revealed that the serum iron level was positively correlated with femoral T and Z scores, whereas the serum hepcidin level was not. Serum hepcidin level was correlated with the serum 25-hydroxy vitamin D level, which was in turn positively related to the femoral Z score. Serum hepcidin and serum iron were indirectly and directly related to osteoporosis in patients with RA. Nature Publishing Group UK 2020-06-18 /pmc/articles/PMC7303107/ /pubmed/32555299 http://dx.doi.org/10.1038/s41598-020-66945-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Sato, Hiroe
Takai, Chinatsu
Kazama, Junichiro James
Wakamatsu, Ayako
Hasegawa, Eriko
Kobayashi, Daisuke
Kondo, Naoki
Nakatsue, Takeshi
Abe, Asami
Ito, Satoshi
Ishikawa, Hajime
Kuroda, Takeshi
Suzuki, Yoshiki
Narita, Ichiei
Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis
title Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis
title_full Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis
title_fullStr Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis
title_full_unstemmed Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis
title_short Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis
title_sort serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303107/
https://www.ncbi.nlm.nih.gov/pubmed/32555299
http://dx.doi.org/10.1038/s41598-020-66945-3
work_keys_str_mv AT satohiroe serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis
AT takaichinatsu serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis
AT kazamajunichirojames serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis
AT wakamatsuayako serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis
AT hasegawaeriko serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis
AT kobayashidaisuke serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis
AT kondonaoki serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis
AT nakatsuetakeshi serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis
AT abeasami serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis
AT itosatoshi serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis
AT ishikawahajime serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis
AT kurodatakeshi serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis
AT suzukiyoshiki serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis
AT naritaichiei serumhepcidinlevelironmetabolismandosteoporosisinpatientswithrheumatoidarthritis